Ordreindtastning
Denmark
Orders LinkContactUsLinkComponent
HetaSep™ Erythrocyte Aggregation Agents

HetaSep™ Erythrocyte Aggregation Agents

HetaSep™ erythrocyte aggregation agent, 100 ml
Katalog # STMC07906
Marketsource
Leverandør:   Stemcell Technologies
HetaSep™ Erythrocyte Aggregation Agents
Katalog # STMC07906
Leverandør:  Stemcell Technologies
Marketsource
HetaSep™ Erythrocyte Aggregation Agents
HetaSep™ Erythrocyte Aggregation Agents

HetaSep™ erythrocyte aggregation agent, 100 ml

Price
1.361,00 kr
Log ind for tilgængelighed
1 * 100 mL
Product Details & Documents

For depletion of red blood cells from fresh blood samples and isolation of nucleated cells.

HetaSep™ is an erythrocyte aggregation agent used to quickly separate nucleated cells from red blood cells (RBCs) in whole blood. Aggregated erythrocytes settle much faster than dispersed cells. By controlling the settling time and/or centrifugation speed, the majority of nucleated cells are recovered in the supernatant. Approximately 95 to 99% RBC depletion is attained if the nucleated cell-rich fraction is removed carefully. HetaSep™ contains 6% w/v hetastarch.

Advarsel: Product Restrictions: (i) Customer shall not make products or any portion of them, in any way, shape or form, including as a component of another product available for the purpose of further resale or alter or remove the Product label and the Supplier’s mark of origin without express written permission of Supplier; and (ii) Customer is familiar with Supplier’s restrictions on the use of the Products and shall use the Products in compliance with such restrictions and the applicable Supplier Product Information sheet (collectively, the ‘Product Restrictions’).

Specifikationer
  • Beskrivelse:
    HetaSep™ erythrocyte aggregation agent, 100 ml
  • Seq:
    02
Anbefalinger

Recommendations will be personalized based on your shopping preferences only if you have given your consent by enabling "Enhance my Shopping Experience" on the "Personal Info page".

Otherwise, you will receive generic recommendations.